|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chow PK, Choo SP, Ng DC, Lo RH, Wang ML,
Toh HC, Tai DW, Goh BK, Wong JS, Tay KH, et al: National cancer
centre Singapore consensus guidelines for hepatocellular carcinoma.
Liver Cancer. 5:97–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang GH, Lan R, Zhen XD, Zhang W, Xiang J
and Cai DF: An-Gong-Niu-Huang Wan protects against cerebral
ischemia induced apoptosis in rats: Up-regulation of Bcl-2 and
down-regulation of Bax and caspase-3. J Ethnopharmacol.
154:156–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu YF, Wu Q, Liang SX, Miao JW, Shi JS and
Liu J: Evaluation of hepatotoxicity potential of
cinnabar-containing An-Gong-Niu-Huang Wan, a patent traditional
Chinese medicine. Regul Toxicol Pharmacol. 60:206–211. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan SK, Xin WF, Luo GA, Wang YM and Cheng
YY: An approach to develop two-dimensional fingerprint for the
quality control of Qingkailing injection by high-performance liquid
chromatography with diode array detection. J Chromatogr A.
1090:90–97. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zender L, Spector MS, Xue W, Flemming P,
Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, et
al: Identification and validation of oncogenes in liver cancer
using an integrative oncogenomic approach. Cell. 125:1253–1267.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kowalik MA, Saliba C, Pibiri M, Perra A,
Ledda-Columbano GM, Sarotto I, Ghiso E, Giordano S and Columbano A:
Yes-associated protein regulation of adaptive liver enlargement and
hepatocellular carcinoma development in mice. Hepatology.
53:2086–2096. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang T, Zhang J, You X, Liu Q, Du Y, Gao
Y, Shan C, Kong G, Wang Y, Yang X, et al: Hepatitis B virus X
protein modulates oncogene Yes-associated protein by CREB to
promote growth of hepatoma cells. Hepatology. 56:2051–2059. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Wang S, Wang G, Zhang Z, Wu X, Zhang
T, Fu B and Chen G: Yes-associated protein expression is a
predictive marker for recurrence of hepatocellular carcinoma after
liver transplantation. Dig Surg. 31:468–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mauviel A, Nallet-Staub F and Varelas X:
Integrating developmental signals: A Hippo in the (path)way.
Oncogene. 31:1743–1756. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lamar JM, Stern P, Liu H, Schindler JW,
Jiang ZG and Hynes RO: The Hippo pathway target, YAP, promotes
metastasis through its TEAD-interaction domain. Proc Natl Acad Sci
USA. 109:pp. E2441–E2450. 2012, View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan SW, Lim CJ, Chong YF, Pobbati AV,
Huang C and Hong W: Hippo pathway-independent restriction of TAZ
and YAP by angiomotin. J Biol Chem. 286:7018–7026. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee KP, Lee JH, Kim TS, Kim TH, Park HD,
Byun JS, Kim MC, Jeong WI, Calvisi DF, Kim JM, et al: The
Hippo-Salvador pathway restrains hepatic oval cell proliferation,
liver size, and liver tumorigenesis. Proc Natl Acad Sci USA.
107:pp. 8248–8253. 2010, View Article : Google Scholar : PubMed/NCBI
|
